Enveric Biosciences (ENVB) announced that its board of directors has authorized the company’s capital markets committee to explore and negotiate non-binding term sheets for potential digital asset treasury strategy opportunities. Any such opportunities will be subject to further review and approval by the full board.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ENVB:
- Psychedelic: Enveric announces EB-003 manufacturing milestones
- Enveric Biosciences completes key manufacturing milestones for EB-003
- Enveric Biosciences files to sell 5.02M shares of common stock for holders
- Enveric Biosciences Closes Warrant Exercise Deal
- Enveric Biosciences publishes two peer-reviewed research papers